Informa Life Sciences is part of the Knowledge and Networking Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.
Chief Scientific Officer at Carterra
Dr. Abdiche joined Wasatch Microfluidics as CSO in 2016 after twelve and half years’ experience in the pharmaceutical industry as a Research Fellow at Rinat-Pfizer, where she was a member of Rinat’s leadership team, served on the governing committee for Pfizer’s Post-doctoral Program, and led a group of analytical scientists that applied label-free biosensors to the discovery of therapeutic antibodies. After graduating from Oxford University in the UK with a PhD in Biological Chemistry and a Master’s degree in Chemistry, Dr. Abdiche completed post-doctoral research in Dr. David Myszka’s laboratory at the University of Utah in Salt Lake City, where she optimized biosensor methods for characterizing small molecule interactions and helped to establish carbonic anhydrase as a benchmark model system. Dr. Abdiche is co-inventor of several therapeutic antibodies in clinical trials, including TEV-48125 (formerly RN307), an anti-CGRP antibody which is currently in PhIII clinical trials for migraine, bococizumab, a PCSK9 inhibitor that was tested in PhIII clinical trials for hypercholesteremia, and RN888, a PD-1 inhibitor currently in PhI clinical trials for cancer immunotherapy.